NCT02691611View on ClinicalTrials.gov

Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2018

Study Completion Date

July 31, 2020

Conditions
Alpha 1-Antitrypsin Deficiency
Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

National Jewish Health

OTHER

NCT02691611 - Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency | Biotech Hunter | Biotech Hunter